Aspiriant LLC’s Palo Alto Networks PANW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$590K Buy
3,682
+1,250
+51% +$210K 0.02% 198
2025
Q4
$448K Buy
2,432
+588
+32% +$119K 0.01% 230
2025
Q3
$375K Sell
1,844
-653
-26% -$125K 0.01% 225
2025
Q2
$511K Buy
2,497
+204
+9% +$37.9K 0.02% 194
2025
Q1
$391K Buy
2,293
+233
+11% +$43.1K 0.01% 209
2024
Q4
$375K Buy
2,060
+288
+16% +$54.4K 0.01% 215
2024
Q3
$303K Buy
1,772
+4
+0.2% +$673 0.01% 230
2024
Q2
$300K Sell
1,768
-370
-17% -$55.3K 0.01% 230
2024
Q1
$304K Buy
2,138
+20
+0.9% +$3.15K 0.01% 243
2023
Q4
$312K Buy
2,118
+6
+0.3% +$802 0.01% 234
2023
Q3
$248K Buy
2,112
+6
+0.3% +$710 0.01% 249
2023
Q2
$269K Sell
2,106
-470
-18% -$48.9K 0.01% 239
2023
Q1
$257K Buy
+2,576
New +$218K 0.01% 236
2022
Q4
Sell
-2,754
Closed -$225K 287
2022
Q3
$225K Sell
2,754
-42
-2% -$3.64K 0.01% 241
2022
Q2
$230K Sell
2,796
-768
-22% -$68.1K 0.01% 246
2022
Q1
$370K Buy
3,564
+678
+23% +$60.7K 0.02% 200
2021
Q4
$268K Buy
2,886
+132
+5% +$11.4K 0.01% 239
2021
Q3
$220K Buy
+2,754
New +$193K 0.01% 219

Other funds holding PANW

Aspiriant LLC's PANW Position: Q1 2026 in Review

Aspiriant LLC increased its Palo Alto Networks (PANW) stake by 51% in Q1 2026, buying an estimated $210K and bringing the position to 3,682 shares worth $590K. The position accounts for 0.02% of the portfolio, ranked #198.

Aspiriant LLC first reported a position in PANW in Q3 2021 and has held it in 18 quarters since. 2,459 funds tracked by Wall St. Rank hold PANW as of Q1 2026.

  • Aspiriant LLC held 3,682 shares of Palo Alto Networks worth $590K as of Q1 2026.
  • Aspiriant LLC bought 1,250 Palo Alto Networks shares in Q1 2026, an estimated $210K.
  • Palo Alto Networks made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #198 holding.
  • Aspiriant LLC first reported a position in Palo Alto Networks in Q3 2021 and has held it in 18 quarters since.
  • 2,459 funds tracked by Wall St. Rank held Palo Alto Networks as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.